A large study of more than 36,000 adults across 14 countries found that migraine burden rises smoothly with attack frequency, with no sharp jump at the chronic migraine threshold. The...

A new meta-analysis of 19 randomized trials weighs whether CGRP migraine preventives like erenumab raise blood pressure, and what it means for monitoring.

A 2026 real-world meta-analysis found fremanezumab cut monthly migraine days by nearly 6, with about half of people achieving a 50% or greater drop in attacks. Here is what it...

A large Neurology study measured plasma CGRP in 588 people with migraine and found levels were lower than in healthy controls, not higher, and did not track with attacks or...

Sleep and migraine run on shared brain circuits, so each affects the other. Learn the triggers, the weekend lie-in trap, sleep habits that help, and when to check for apnea.

Migraine in kids and teens looks different: shorter, both-sided, stomach-heavy attacks. Learn how to treat them, why lifestyle leads prevention, and the red flags to watch.

Migraines that strike around your period are driven by an estrogen drop. Learn the menstrual window, the two types, timed prevention, and the aura safety rule.

Retinal migraine causes brief vision loss in one eye. Learn how to tell it apart from a stroke, how it is diagnosed, which triggers matter, and how it is treated.

A new Neurology study of 130,000 postmenopausal women followed for two decades finds a history of migraine is linked to a modest increase in ischemic stroke risk, with no rise...

Crown is the first migraine roller built on evidence from two traditions. Menthol with the strongest clinical backing, Bing Pian and Chuan Xiong from traditional Chinese medicine, and magnesium. Here's...

If you've been told your migraine attacks are damaging your brain or that the side they're on predicts anxiety or PTSD, the evidence doesn't support it.

The American Headache Society (AHS) has released its 2025 guideline update for the acute treatment of migraine in adults presenting to the emergency department. This update, published in Headache in...

A comprehensive meta-analysis of over 4,300 patients reveals that erenumab, galcanezumab, fremanezumab, and eptinezumab maintain good tolerability beyond 12 months. Only 3% of patients stopped treatment due to adverse events,...

Alternate nostril breathing is a simple yogic technique that's showing real promise for migraine prevention. Unlike acute treatments, this practice builds nervous system resilience over time - making attacks less...

A 2025 systematic review of over 10,000 patients confirms a strong bidirectional link between migraine and temporomandibular disorders. People with migraine are 6 times more likely to develop TMD, while...

First-ever eptinezumab (Vyepti) desensitization protocol for migraine patients with hypersensitivity reactions. 10-step hospital-based approach proven safe and effective.

This guide provides comprehensive, evidence-based recommendations for migraine management throughout the reproductive journey.